Citation Impact
Citing Papers
Expanded therapeutic potential in activity space of next-generation 5-nitroimidazole antimicrobials with broad structural diversity
2013 StandoutNobel
Systemic 4-1BB activation induces a novel T cell phenotype driven by high expression of Eomesodermin
2013 StandoutNobel
Computational Thermostabilization of an Enzyme
2005 StandoutScienceNobel
Macrophage-Derived SPARC Bridges Tumor Cell-Extracellular Matrix Interactions toward Metastasis
2008
Hypoxia Response Elements in the Aldolase A, Enolase 1, and Lactate Dehydrogenase A Gene Promoters Contain Essential Binding Sites for Hypoxia-inducible Factor 1
1996 StandoutNobel
Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition
2006 StandoutNobel
Genome-wide Association of Hypoxia-inducible Factor (HIF)-1α and HIF-2α DNA Binding with Expression Profiling of Hypoxia-inducible Transcripts
2009 StandoutNobel
Platelet factor 4–induced T H 1-T reg polarization suppresses antitumor immunity
2024 StandoutScienceNobel
Up‐regulation of gene expression by hypoxia is mediated predominantly by hypoxia‐inducible factor 1 (HIF‐1)
2005
Suppression of tumor growth through disruption of hypoxia-inducible transcription
2000 StandoutNobel
Cellular and Gene Expression Responses Involved in the Rapid Growth Inhibition of Human Cancer Cells by RNA Interference-mediated Depletion of Telomerase RNA
2005 StandoutNobel
Inflammation and cancer
2002 StandoutNature
β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
1999 StandoutNature
WAF1, a potential mediator of p53 tumor suppression
1993 Standout
Defects in a cell cycle checkpoint may be responsible for the genomic instability of cancer cells
1992 StandoutNobel
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Host tissue determinants of tumour immunity
2019
p53, the Cellular Gatekeeper for Growth and Division
1997 Standout
Soluble adhesion molecules (E-selectin, ICAM-1 and VCAM-1) in breast carcinoma
2002
The αvintegrin antagonists as novel anticancer agents: an update
2002
Genetic instabilities in human cancers
1998 StandoutNature
When Checkpoints Fail
1997 StandoutNobel
Mechanism of Activation of the RAF-ERK Signaling Pathway by Oncogenic Mutations of B-RAF
2004 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Role of the Microbiota in Immunity and Inflammation
2014 Standout
Functional Role of G9a Histone Methyltransferase in Cancer
2015
A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia-telangiectasia
1992 Standout
Invasive and Metastatic Potential of a v-Ha-ras-Transformed Human Bronchial Epithelial Cell Line
1989
Gene directed enzyme/prodrug therapy of cancer: Historical appraisal and future prospectives
2001
Cell Adhesion: The Molecular Basis of Tissue Architecture and Morphogenesis
1996 Standout
HIF-1α Is Essential for Myeloid Cell-Mediated Inflammation
2003 Standout
Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53
1992
Genetic instability in colorectal cancers
1997 StandoutNature
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
2004 Standout
p53 is required for radiation-induced apoptosis in mouse thymocytes
1993 StandoutNature
Fusobacterium nucleatum Promotes Colorectal Carcinogenesis by Modulating E-Cadherin/β-Catenin Signaling via its FadA Adhesin
2013 Standout
Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation
1991 Standout
p63 is a p53 homologue required for limb and epidermal morphogenesis
1999 StandoutNature
The basics of epithelial-mesenchymal transition
2009 Standout
p53-dependent apoptosis modulates the cytotoxicity of anticancer agents
1993 Standout
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
2001 Standout
Perspectives on Oxygen Sensing
1999 StandoutNobel
Investigation of the role of macrophages on the cytotoxicity of doxorubicin and doxorubicin-loaded nanoparticles on M5076 cells in vitro
2000
Genes that mediate breast cancer metastasis to lung
2005 StandoutNature
Mice Lacking p21CIP1/WAF1 undergo normal development, but are defective in G1 checkpoint control
1995 Standout
Tumor Angiogenesis
2008 Standout
Multiple ways of silencing E-cadherin gene expression in lobular carcinoma of the breast
2001
SPI-CI and SPI-6 cooperate in the protection from effector cell–mediated cytotoxicity
2004
Crystal Structure of a p53 Tumor Suppressor-DNA Complex: Understanding Tumorigenic Mutations
1994 StandoutScience
Functional implications of nitric oxide produced by mitochondria in mitochondrial metabolism
1998
Cancer Cell Cycles
1996 StandoutScience
Cell Cycle Control and Cancer
1994 StandoutScienceNobel
Mitotic checkpoint genes in budding yeast and the dependence of mitosis on DNA replication and repair.
1994 StandoutNobel
Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma.
1996 Standout
Nitroreductase (GlNR1) increases susceptibility of Giardia lamblia and Escherichia coli to nitro drugs
2011
Normal diploid human and rodent cells lack a detectable frequency of gene amplification.
1990
Cell and Environment Interactions in Tumor Microregions: The Multicell Spheroid Model
1988 StandoutScience
Increased Plasma Vascular Endothelial Growth Factor (VEGF) as a Surrogate Marker for Optimal Therapeutic Dosing of VEGF Receptor-2 Monoclonal Antibodies
2004
Hypoxic Stress Induces Dimethylated Histone H3 Lysine 9 through Histone Methyltransferase G9a in Mammalian Cells
2006
Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasiveness
1994
Hypoxia-inducible factor-1 modulates gene expression in solid tumors and influences both angiogenesis and tumor growth
1997 StandoutNobel
Biological consequences of tumor hypoxia.
2001
Annexins: From Structure to Function
2002 Standout
G 1 Events and Regulation of Cell Proliferation
1989 StandoutScience
Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APC
1997 StandoutScience
Lack of BRAF Mutation in Primary Uveal Melanoma
2003
Survey of Studies Examining Mammalian Cardiomyocyte DNA Synthesis
1998
The Biology of Chemokines and their Receptors
2000 Standout
Methylation of hypoxia-inducible factor (HIF)-1α by G9a/GLP inhibits HIF-1 transcriptional activity and cell migration
2018 StandoutNobel
Metal–Organic Frameworks in Biomedicine
2011 Standout
Quantitative genetic analysis of tumor progression
1985
High rate of CAD gene amplification in human cells deficient in MLH1 or MSH6
2001 StandoutNobel
Loss of E-Cadherin-Dependent Cell-Cell Adhesion due to Mutation of the β-Catenin Gene in a Human Cancer Cell Line, HSC-39
1995
Cell Cycle Checkpoints: Preventing an Identity Crisis
1996 StandoutScience
Evidence for Cardiomyocyte Renewal in Humans
2009 StandoutScience
Works of IR Hart being referenced
Proliferating cell nuclear antigen expression in non-cycling cells may be induced by growth factors in vivo
1994
Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome
1995
Tumour cell expression of B7 costimulatory molecules and interleukin-12 or granulocyte–macrophage colony-stimulating factor induces a local antitumour response and may generate systemic protective immunity
1998
Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability
1998
Expression of αv integrins and vitronectin receptor identity in breast cancer cells
1998
Comparative analysis of integrins in vitro and in vivo in uveal and cutaneous melanomas
1998
Mechanisms of tumour metastasis
1998
Investigation of alternative prodrugs for use with E. coli nitroreductase in 'suicide gene' approaches to cancer therapy.
1996
Inhibited growth of a reticulum cell sarcoma (M5076) induced in vitro and in vivo by macrophage-activating agents.
1984
Identification by differential display of annexin-VI, a gene differentially expressed during melanoma progression.
1996
E-cadherin expression in colorectal cancer. An immunocytochemical and in situ hybridization study.
1993
Tumor cell hybridization and neoplastic progression.
1983
The development of biological diversity and metastatic potential in malignant neoplasms.
1982